{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:44:30Z","timestamp":1759776270346},"posted":{"date-parts":[[2023,10,4]]},"group-title":"In Review","reference-count":38,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Long-term antiretroviral therapy (ART) perpetually suppresses HIV load and has dramatically altered the prognosis of HIV infection, such that HIV is now regarded as a chronic disease.  Side effects of ART in Patients With HIV (PWH), has introduced new challenges including \u201cmetabolic\u201d (systemic) and oral complications. Furthermore, inflammation persists despite great viral load suppression and normal levels of CD4<jats:sup>+<\/jats:sup> cell count.\nThe impact of ART on the spectrum of oral diseases among PWH is often overlooked relative to other systemic complications. There is paucity of data on oral complications associated with ART use in PWH. This is in part due to limited prospective longitudinal studies designed to better understand the range of oral abnormalities observed in PWH on ART. Our group designed and implemented a prospective observational longitudinal study to address this gap.\nWe present a procedural roadmap that could be modelled to assess the extent and progression of oral diseases associated with ART in PWH. We described here the processes associated with subject recruitment and retention, study visit planning, oral health assessments, bio-specimen collection and preprocessing procedures, and data management.   We also highlighted the rigors and challenges associated with participant recruitment and retention.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3390162\/v1","type":"posted-content","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T17:06:15Z","timestamp":1696439175000},"source":"Crossref","is-referenced-by-count":1,"title":["Oral Health Outcomes In An HIV Cohort With Comorbidities- Implementation Roadmap For A Longitudinal Prospective Observational Study"],"prefix":"10.21203","author":[{"given":"Temitope","family":"Omolehinwa","sequence":"first","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunday O.","family":"Akintoye","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gabinskiy","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Lo","family":"Re","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Mupparapu","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Urbina","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Schaubel","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Corby","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","article-title":"Long-acting antiretrovirals and HIV treatment adherence","volume":"10","author":"Nachega JB","year":"2023","unstructured":"Nachega JB, Scarsi KK, Gandhi M, Scott RK, Mofenson LM, Archary M, et al. Long-acting antiretrovirals and HIV treatment adherence. Lancet HIV. 2023;10(5):e332\u2013e42.","journal-title":"Lancet HIV"},{"key":"ref2","unstructured":"(WHO) WHO. HIV and AIDS https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids2023."},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11904-012-0147-3","article-title":"Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy","volume":"10","author":"Taiwo B","year":"2013","unstructured":"Taiwo B, Barcena L, Tressler R. Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy. Curr HIV\/AIDS Rep. 2013;10(1):21\u201332.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2017.00241","article-title":"HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation","volume":"8","author":"Heron SE","year":"2017","unstructured":"Heron SE, Elahi S. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. Front immunol. 2017;8:241.","journal-title":"Front immunol"},{"issue":"9491","key":"ref5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti KG","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, Group I. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366(9491):1059\u201362.","journal-title":"Lancet"},{"key":"ref6","first-page":"eCollection","article-title":"Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy","volume":"6238978","author":"Ahmed D","year":"2018","unstructured":"Ahmed D, Roy D, Cassol E. Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy. Mediators Inflamm. 2018;6238978:eCollection.","journal-title":"Mediators Inflamm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0956462417732226","article-title":"Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and\/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis","author":"Echecopar-Sabogal J","year":"2018","unstructured":"Echecopar-Sabogal J, D'Angelo-Piaggio L, Chanam\u00e9-Baca DM, Ugarte-Gil C. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and\/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis. Int J STD AIDS. 2018. p. 443\u201352.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11904-016-0330-z","article-title":"Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence","volume":"13","author":"Willig AL","year":"2016","unstructured":"Willig AL, Overton ET. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence. Curr HIV\/AIDS Rep. 2016;13(5):289\u201396.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11883-010-0152-1","article-title":"Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection","volume":"13","author":"Troll JG","year":"2011","unstructured":"Troll JG. Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection. Curr Atheroscler Rep. 2011;13(1):51\u20136.","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"ref10","first-page":"228","article-title":"Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation","volume":"20","author":"Pandiyan P","year":"2016","unstructured":"Pandiyan P, Younes SA, Ribeiro SP, Talla A, McDonald D, Bhaskaran N, et al. Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation. Front Immunol. 2016;20(7):228.","journal-title":"Front Immunol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","DOI":"10.3390\/v11030200","article-title":"Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART","volume":"11","author":"Zicari S","year":"2019","unstructured":"Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C et al. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART. Viruses. 2019;11(3).","journal-title":"Viruses"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12879-017-2626-z","article-title":"Cardiovascular risk and dyslipidemia among persons living with HIV: a review","volume":"17","author":"Maggi P","year":"2017","unstructured":"Maggi P, Di Biagio A, Rusconi S, Cicalini S, D'Abbraccio M, d'Ettorre G, et al. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis DIseases. 2017;17(1):551.","journal-title":"BMC Infect Dis DIseases"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.00409-12","article-title":"Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load","volume":"56","author":"Kramer VG","year":"2012","unstructured":"Kramer VG, Schader SM, Oliveira M, Colby-Germinario SP, Donahue DA, Singhroy DN, et al. Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load. Antimicrob Agents Chemother. 2012;56(8):4154\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref14","first-page":"61","article-title":"Ageing with HIV - a periodontal perspective","volume":"41","author":"Tolji\u0107 B","year":"2018","unstructured":"Tolji\u0107 B, Trbovich AM, Petrovi\u0107 SM, Kannosh IY, Dragovi\u0107 G, Jevtovi\u0107 D, et al. Ageing with HIV - a periodontal perspective. New Microbiol. 2018;41(1):61\u20136.","journal-title":"New Microbiol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/1744666X.2018.1459571","article-title":"Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis. London","volume":"14","author":"P\u00f3lvora TLS","year":"2018","unstructured":"P\u00f3lvora TLS, Nobre \u00c1VV, Tirapelli C, Taba M, Macedo LDd, Santana RC, et al. Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis. London. Expert Rev Clin Immunol. 2018;14(4):315\u201327.","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"ref16","article-title":"Oral Manifestations Associated with HIV\/AIDS Patients","volume":"58","author":"Lomel\u00ed-Mart\u00ednez SM","year":"2022","unstructured":"Lomel\u00ed-Mart\u00ednez SM, Gonz\u00e1lez-Hern\u00e1ndez LA, Ruiz-Anaya AJ, Lomel\u00ed-Mart\u00ednez MA, Mart\u00ednez-Salazar SY, Mercado Gonz\u00e1lez AE et al. Oral Manifestations Associated with HIV\/AIDS Patients. Med (Kaunas). 2022;58(9).","journal-title":"Med (Kaunas)"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4 + T cells","volume":"200","author":"French MA","year":"2009","unstructured":"French MA, King MS, Tschampa JM, da Silva BA, Landay AL. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4 + T cells. J Infect Dis. 2009;200(8):1212\u20135.","journal-title":"J Infect Dis"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/joor.12664","article-title":"Salivary secretion in health and disease","volume":"45","author":"Pedersen AML","year":"2018","unstructured":"Pedersen AML, S\u00f8rensen CE, Proctor GB, Carpenter GH, Ekstr\u00f6m J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730\u201346.","journal-title":"J Oral Rehabil"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"E2747","DOI":"10.3390\/ijms19092747","article-title":"Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands","volume":"19","author":"Nizamuddin I","year":"2018","unstructured":"Nizamuddin I, Koulen P, McArthur CP. Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands. Int J Mol Sci. 2018;19(9):E2747.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/QAD.0000000000001965","article-title":"The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth","volume":"32","author":"Shiboski CH","year":"2018","unstructured":"Shiboski CH, Yao TJ, Russell JS, Ryder MI, Van Dyke RB, Seage GR, et al. The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth. AIDS. 2018;32(17):2497\u2013505.","journal-title":"AIDS"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/154407370601900112","article-title":"Oral lesions of HIV disease and HAART in industrialized countries","volume":"19","author":"Hodgson TA","year":"2006","unstructured":"Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv dent res. 2006;19(1):57\u201362.","journal-title":"Adv dent res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MED.0b013e32833f48d6","article-title":"HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture","volume":"17","author":"Ofotokun I","year":"2010","unstructured":"Ofotokun I, Weitzmann MN. HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Curr Opin Endocrinol Diabetes Obes. 2010;17(6):523\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1875-595X.2004.tb00268.x","article-title":"Dental and oral lesions in HIV infected patients","volume":"54","author":"Pinheiro A","year":"2004","unstructured":"Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients. Int Dent J. 2004;54(3):131\u20137.","journal-title":"Int Dent J"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/10872910050206540","article-title":"Oral lesions in HIV\/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?","volume":"14","author":"Ceballos-Salobre\u00f1a A","year":"2000","unstructured":"Ceballos-Salobre\u00f1a A, Gait\u00e1n-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV\/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDs. 2000;14(12):627\u201335.","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"ref25","first-page":"123","article-title":"Role of RANKL-RANK\/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection","volume":"16","author":"Kelesidis T","year":"2014","unstructured":"Kelesidis T, Currier JS, Yang OO, Brown TT. Role of RANKL-RANK\/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014;16(3):123\u201333.","journal-title":"AIDS Rev"},{"issue":"1","key":"ref26","first-page":"22","article-title":"Bone health in HIV and hepatitis B or C infections","volume":"9","author":"Biver E","year":"2017","unstructured":"Biver E, Calmy A, Rizzoli R. Bone health in HIV and hepatitis B or C infections. TAMD. 2017;9(1):22\u201334.","journal-title":"TAMD"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fendo.2019.00302","article-title":"Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.Front Endocrinol","volume":"10","author":"Dalla GE","year":"2019","unstructured":"Dalla GE, Rigo F, Lanzafame M, Lattuada E, Suardi S, Mottes M, et al. Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.Front Endocrinol. (Lausanne). 2019;10:302.","journal-title":"(Lausanne)"},{"issue":"6717","key":"ref28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong YY","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397(6717):315\u201323.","journal-title":"Nature"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4049\/jimmunol.176.1.625","article-title":"Bacterial-responsive B lymphocytes induce periodontal bone resorption","volume":"176","author":"Han X","year":"2006","unstructured":"Han X, Kawai T, Eastcott JW, Taubman MA. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol. 2006;176(1):625\u201331.","journal-title":"J Immunol"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e32836378c3","article-title":"Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia","volume":"27","author":"Assoumou L","year":"2013","unstructured":"Assoumou L, Katlama C, Viard JP, Bentata M, Simon A, Roux C, et al. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia. AIDS. 2013;27(15):2425\u201330.","journal-title":"AIDS"},{"issue":"17","key":"ref31","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown TT","year":"2006","unstructured":"Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17):2165\u201374.","journal-title":"AIDS"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.13107\/jocr.2023.v13.i05.3668","article-title":"Anti-retroviral Therapy-Induced Multiple Pathological Fractures in a HIV-Positive Young Female: A Case Report and Review of Literature","volume":"13","author":"Subith S","year":"2023","unstructured":"Subith S, Tungenwar S, Avhad T, Apte T, Dakhode S. Anti-retroviral Therapy-Induced Multiple Pathological Fractures in a HIV-Positive Young Female: A Case Report and Review of Literature. J Orthop Case Rep. 2023;13(5):111\u20135.","journal-title":"J Orthop Case Rep"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11547-017-0798-7","article-title":"Xerostomia Quality of Life Scale (XeQoLS) questionnaire: validation of Italian version in head and neck cancer patients","volume":"123","author":"Lastrucci L","year":"2018","unstructured":"Lastrucci L, Bertocci S, Bini V, Borghesi S, De Majo R, Rampini A, et al. Xerostomia Quality of Life Scale (XeQoLS) questionnaire: validation of Italian version in head and neck cancer patients. Radiol Med. 2018;123(1):44\u20137.","journal-title":"Radiol Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1368-8375(00)00063-4","article-title":"Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy","volume":"37","author":"Henson BS","year":"2001","unstructured":"Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral oncol. 2001;37(1):84\u201393.","journal-title":"Oral oncol"},{"key":"ref35","unstructured":"Control CfD. ORAL HEALTH \u2013 Target Group: SPs 1 + 2011 [Available from: https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/ohq.pdf."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2019.07.012","article-title":"Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy","volume":"142","author":"Bagley AF","year":"2020","unstructured":"Bagley AF, Ye R, Garden AS, Gunn GB, Rosenthal DI, Fuller CD, et al. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol. 2020;142:133\u20139.","journal-title":"Radiother Oncol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/ciac857","article-title":"Antibiotic Prophylaxis in Dentistry","volume":"76","author":"Thornhill MH","year":"2023","unstructured":"Thornhill MH, Dayer M, Prendergast BD, Lockhart P, Baddour L. Antibiotic Prophylaxis in Dentistry. Clin Infect Dis. 2023;76(5):960\u20131.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1359\/JBMR.041115","article-title":"Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence","volume":"20","author":"Binkley N","year":"2005","unstructured":"Binkley N, Kiebzak GM, Lewiecki EM, Krueger D, Gangnon RE, Miller PD, et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. JBMR. 2005;20(2):195\u2013201.","journal-title":"JBMR"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390162\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390162\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:25:49Z","timestamp":1698074749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390162\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":38,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3390162\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12903-023-03527-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,10,4]]},"subtype":"preprint"}}